Literature DB >> 27273692

Two familial cases of Olmsted-like syndrome with a G573V mutation of the TRPV3 gene.

Y P Zhi1, J Liu2, J W Han2, Y P Huang2, Z Q Gao1, Y Yang3, R N Wu1.   

Abstract

Olmsted syndrome (OS) is a rare disease, characterized by symmetrical, sharply defined, hyperkeratotic, mutilating plaques on the palms and soles, which are associated with periorificial keratotic plaques. Other clinical manifestations of OS include diffuse alopecia, leucokeratosis of the oral mucosa, onychodystrophy, hyperkeratotic linear streaks, follicular hyperkeratosis and constriction of the digits. A recent study identified de novo mutations in the gene for transient receptor potential vanilloid 3 (TRPV3), causing constitutive activation of the TRPV3 channel, as a cause of OS. We report familial inheritance of OS in a family from Mongolia, which was caused by a previously undescribed G573V point mutation in TRPV3. To date, mutations in the G573 residue of TRPV3 have been reported in seven cases of OS: G573S in five cases, and G573C and G573A mutations in one case each. We present a Mongolian familial case of G573V point mutation in TRPV3.
© 2016 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27273692     DOI: 10.1111/ced.12833

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  3 in total

Review 1.  Role of the TRPV Channels in the Endoplasmic Reticulum Calcium Homeostasis.

Authors:  Aurélien Haustrate; Natalia Prevarskaya; V'yacheslav Lehen'kyi
Journal:  Cells       Date:  2020-01-28       Impact factor: 6.600

2.  Conserved allosteric pathways for activation of TRPV3 revealed through engineering vanilloid-sensitivity.

Authors:  Feng Zhang; Kenton Jon Swartz; Andres Jara-Oseguera
Journal:  Elife       Date:  2019-01-15       Impact factor: 8.140

3.  Case of Olmsted Syndrome with Essential Thrombocytosis Misdiagnosed as Acrodermatitis Enteropathica.

Authors:  Filiz Topaloğlu Demir; Ceyda Çaytemel; Nazlı Caf; Zafer Türkoğlu; Mesut Ayer; Nesimi Büyükbabani
Journal:  Indian J Dermatol       Date:  2021 Sep-Oct       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.